PROGNOSTIC VALUE OF 3D MYOCARDIAL CONTRAST ENHANCED STRESS ECHOCARDIOGRAPHY

Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography.

BACKGROUND Myocardial perfusion (MP) imaging with real-time contrast echocardiography (RTCE) improves the sensitivity of dobutamine stress echocardiography for detecting coronary artery disease. Its prognostic value is unknown. We sought to determine the value of MP and wall motion (WM) analysis during dobutamine stress echocardiography in predicting the outcome of patients with known or suspec...

Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography.

AIMS The aim of this prospective study was to determine long-term prognostic value of myocardial contrast echocardiography (MCE) combined with high-dose dipyridamole stress echocardiography (DSE) in patients undergoing diagnostic work-up for stable coronary artery disease (CAD). METHODS A total of 202 consecutive patients (67% males, age 57±8 years) with suspected or known stable CAD schedule...

3D Myocardial Contrast Echocardiography

Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography.

BACKGROUND The addition of myocardial perfusion (MP) imaging during dipyridamole real-time contrast echocardiography improves the sensitivity to detect coronary artery disease, but its prognostic value to predict hard cardiac events in large numbers of patients with known or suspected coronary artery disease remains unknown. METHODS AND RESULTS We studied 1252 patients with the use of dipyrid...

Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction.

OBJECTIVES This study sought to determine whether residual myocardial viability determined by myocardial contrast echocardiography (MCE) after acute myocardial infarction (AMI) can predict hard cardiac events. BACKGROUND Myocardial viability detected by MCE has been shown to predict recovery of left ventricular (LV) function in patients with AMI. However, to date no study has shown its value ...